Skip to main content
Clinical Trials/CTRI/2018/01/011157
CTRI/2018/01/011157
Completed
未知

A prospective comparative study of mifepristone followed by misoprostol or ethacridine lactate and oxytocin for second trimester abortions

Project in the Department of Obstetrics and Gynecology0 sites120 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: null- SECOND TRIMESTER ABORTIONS
Sponsor
Project in the Department of Obstetrics and Gynecology
Enrollment
120
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
August 30, 2016
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Project in the Department of Obstetrics and Gynecology

Eligibility Criteria

Inclusion Criteria

  • 1\.Second trimester abortions for medical, social, eugenic reasons
  • 2\.Intrauterine pregnancy
  • 3\.18\-40 years
  • 4\.Consent to participate in the study

Exclusion Criteria

  • 1\.Less than 13 weeks and more than 20 weeks pregnancy terminations
  • 2\.Patients with history of renal disease or hepatic disease or bronchial asthma or hematological disease or glaucoma or heart disease etc
  • 3\.Hemoglobin less than 10 gm/dl
  • 4\.Patients with previous caesarean section and other uterine scars
  • 5\.Symptomatic reproductive tract infections
  • 6\.Hypersensitivity to mifepristone or misoprostol or ethacridine lactate or oxytocin
  • 7\.Rupture of membranes

Outcomes

Primary Outcomes

Not specified

Similar Trials